Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EHMT2 | Q96KQ7 | 1/20 | 0.56 |
| ▸ | F2 | P00734 | 1/20 | 0.50 |
| ▸ | PLG | P00747 | 1/20 | 0.50 |
| ▸ | ELANE | P08246 | 1/20 | 0.50 |
| ▸ | CTSG | P08311 | 1/20 | 0.50 |
| ▸ | CMA1 | P23946 | 1/20 | 0.50 |
| ▸ | CTRC | Q99895 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | EP300 | Q09472 | 2/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.44 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | GSK3A | P49840 | 1/20 | 0.42 |
| ▸ | GSK3B | P49841 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22130803 | 1.00 | EHMT2 (0.56) | EHMT2F2PLGELANECTSG | |
| SCHEMBL353717 | 1.00 | EHMT2 (0.56) | EHMT2F2PLGELANECTSG | |
| SCHEMBL10956698 | 0.93 | EHMT2 (0.50) | EHMT2F2PLGELANECTSG | |
| SCHEMBL5082176 | 0.90 | EHMT2 (0.47) | EHMT2F2PLGELANECTSG | |
| SCHEMBL10721577 | 0.87 | ALDH1A1 (0.50) | EHMT2KMT2AMEN1POLB | |
| SCHEMBL9032781 | 0.87 | ALDH1A1 (0.50) | EHMT2KMT2AMEN1POLB | |
| SCHEMBL9030364 | 0.87 | ALDH1A1 (0.50) | EHMT2KMT2AMEN1POLB | |
| SCHEMBL11177434 | 0.87 | ALDH1A1 (0.50) | EHMT2KMT2AMEN1POLB | |
| SCHEMBL11199133 | 0.87 | ALDH1A1 (0.50) | EHMT2KMT2AMEN1POLB | |
| SCHEMBL9030374 | 0.87 | ALDH1A1 (0.50) | EHMT2KMT2AMEN1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 364 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260042084-A1 | SORBENTS FUNCTIONALIZED WITH LIGANDS HAVING AN AMINOSILICONE FUNCTIONAL GROUP | GENERAL ELECTRIC TECHNOLOGY GMBH (CH) | 2026-02-12 | — | — | US | claimed |
| EP-4680369-A1 | SYSTEMS FOR CARBON DIOXIDE CAPTURE USING FUNCTIONALIZED SORBENTS AND WATER MANAGEMENT | GE Vernova Technology GmbH (CH) | 2026-01-21 | — | — | EP | claimed |
| EP-4572884-A1 | SORBENTS FUNCTIONALIZED WITH LIGANDS HAVING AN AMINOSILICONE FUNCTIONAL GROUP | General Electric Technology GmbH (CH) | 2025-06-25 | — | — | EP | claimed |
| EP-4556112-A2 | SORBENT COMPOSITIONS, SYSTEMS, AND METHODS | General Electric Technology GmbH (CH) | 2025-05-21 | — | — | EP | claimed |
| CN-119869460-A | Sorbent compositions, systems, and methods | 通用电气技术有限公司 | 2025-04-25 | — | — | CN | claimed |
| US-12263464-B2 | Method for in-situ synthesis of metal organic frameworks (MOFs), covalent organic frameworks (COFs) and zeolite imidazolate frameworks (ZIFs), and applications thereof | DESICCANT ROTORS INTERNATIONAL PRIVATE LIMITED (IN) | 2025-04-01 | — | — | US | claimed |
| WO-2024232872-A1 | SYSTEMS FOR CARBON DIOXIDE CAPTURE USING FUNCTIONALIZED SORBENTS AND WATER MANAGEMENT | GENERAL ELECTRIC TECHNOLOGY GMBH (CH) | 2024-11-14 | — | — | WO | claimed |
| CN-118834099-A | Prohexadione water-soluble fertilizer and preparation method thereof | 郑州郑氏化工产品有限公司 | 2024-10-25 | — | — | CN | claimed |
| US-20240199653-A1 | METHOD FOR FORMING AN ELECTRICALLY CONDUCTIVE METAL ORGANIC FRAMEWORK COMPOSITE | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2024-06-20 | — | — | US | claimed |
| WO-2024123903-A1 | SORBENT COMPOSITIONS, SYSTEMS, AND METHODS | GE INFRASTRUCTURE TECHNOLOGY LLC (US) | 2024-06-13 | — | — | WO | claimed |
| EP-2739169-A2 | POROUS CATALYTIC MATRICES FOR ELIMINATION OF TOXICANTS FOUND IN TOBACCO COMBUSTION PRODUCTS | Massachusetts Institute Of Technology (US) | 2014-06-11 | — | — | EP | claimed |
| WO-2013019865-A2 | POROUS CATALYTIC MATRICES FOR ELIMINATION OF TOXICANTS FOUND IN TOBACCO COMBUSTION PRODUCTS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2013-02-07 | — | — | WO | claimed |
| WO-2008071696-A1 | IMPROVED PROCESS FOR PREPARING SUBSTITUTED CARBOXYLIC ANHYDRIDES | DSM IP ASSETS BV (CH) | 2008-06-19 | — | — | WO | claimed |
| EP-1127879-B1 | Preparation of 2-oxo-1,3-dibenzyl-cis-4,5-imidazolidin dicarboxylic acid and its anhydrid | DSM IP ASSETS BV (NL) | 2005-05-25 | — | — | EP | claimed |
| US-6344565-B1 | REACTION OF BIS(BENZYLAMINO)SUCCINIC ACID DIALKALI METAL SALT WITH TRIPHOSGENE, ACIDIFICATION IN WATER | ROCHE VITAMINS, INC. | 2002-02-05 | — | — | US | claimed |
| US-6291681-B1 | REACTING MESO-2,3-BIS(BENZYLAMINO)SUCCINIC ACID DIALKALI METAL SALT WITH PHENYL CHLOROFORMATE; ACIDIFICATION, ISOLATING 2-OXO-1,3-DIBENZYL-CIS-4,5-IMIDAZOLIDINEDICARBOXYLIC ACID; HEATING WITH ACETIC ANHYDRIDE TO PRODUCE ANHYDRIDE COMPOUND | ROCHE VITAMINS INC. | 2001-09-18 | — | — | US | claimed |
| US-20010020101-A1 | Process for preparing biotin | F. HOFFMANN-LA ROCHE AG | 2001-09-06 | — | — | US | claimed |
| US-4739071-A | Process for the preparation of enantiomers | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1988-04-19 | — | — | US | claimed |
| EP-0044158-B1 | NOVEL OPTICALLY ACTIVE IMIDAZOLIDIN-2-ONE DERIVATIVES AND THEIR PRODUCTION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1984-08-15 | — | — | EP | claimed |
| EP-0044158-A1 | Novel optically active imidazolidin-2-one derivatives and their production | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1982-01-20 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010020101-A1 | Process for preparing biotin | OGDH, BTD, DDC | EHMT2 1403/4885F2 1670/4885PLG 1685/4885 |
| US-20260042084-A1 | SORBENTS FUNCTIONALIZED WITH LIGANDS HAVING AN AMINOSILICONE FUNCTIONAL GROUP | SRMS, TYRO3, SELE | EHMT2 756/4885F2 171/4885PLG 2539/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.